Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

September
11
2017

Sensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane Irma

BOCA RATON, Fla., Sept. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that…

September
05
2017

Skin Cancer Treatment: No Cutting, No Scarring, No Long Recovery Times

If you are one of the 3.5 million Americans diagnosed with non-melanoma skin cancer, you have a choice. Skin cancer treatment does not have to be a nightmare. With the SRT-100, patients can choose no…

September
05
2017

SRT: Innovating a Proven Treatment for Skin Cancer Treatment

Innovating upon a tried-and-true technology, an updated device is available for dermatologists to use to fight skin cancer. By Jeffrey Fromowitz, MD, FAAD As a dermatologist in practice in Boca Raton, FL, I am at…

September
05
2017

Sensus Healthcare to Present at Upcoming Investor Conferences

Management unable to present at Liolios Gateway conference due to Hurricane Irma   BOCA RATON, Fla., Sept. 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy